[go: up one dir, main page]

WO1999002659A3 - Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee - Google Patents

Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee Download PDF

Info

Publication number
WO1999002659A3
WO1999002659A3 PCT/EP1998/004265 EP9804265W WO9902659A3 WO 1999002659 A3 WO1999002659 A3 WO 1999002659A3 EP 9804265 W EP9804265 W EP 9804265W WO 9902659 A3 WO9902659 A3 WO 9902659A3
Authority
WO
WIPO (PCT)
Prior art keywords
cyclosporin
synthetase
cyclosporin synthetase
modified
altering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/004265
Other languages
English (en)
Other versions
WO1999002659A2 (fr
Inventor
Kurt Schoergendorfer
Guenther Stempfer
Holger Husi
Malcolm Douglas Walkinshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz GmbH
Original Assignee
Biochemie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie GmbH filed Critical Biochemie GmbH
Priority to EP98937563A priority Critical patent/EP0994943A2/fr
Priority to AU86311/98A priority patent/AU8631198A/en
Publication of WO1999002659A2 publication Critical patent/WO1999002659A2/fr
Publication of WO1999002659A3 publication Critical patent/WO1999002659A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé de modification des domaines de la cyclosporine synthétase pour l'obtention d'une cyclosporine synthétase modifiée, ainsi que des procédés de production de peptides ou de dérivés de type cyclosporine utilisant la cyclosporine synthétase modifiée, et des peptides ou dérivés de type cyclosporine.
PCT/EP1998/004265 1997-07-09 1998-07-09 Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee Ceased WO1999002659A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP98937563A EP0994943A2 (fr) 1997-07-09 1998-07-09 Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee
AU86311/98A AU8631198A (en) 1997-07-09 1998-07-09 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714475.2A GB9714475D0 (en) 1997-07-09 1997-07-09 Organic compounds
GB9714475.2 1997-07-09

Publications (2)

Publication Number Publication Date
WO1999002659A2 WO1999002659A2 (fr) 1999-01-21
WO1999002659A3 true WO1999002659A3 (fr) 1999-05-14

Family

ID=10815609

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004265 Ceased WO1999002659A2 (fr) 1997-07-09 1998-07-09 Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee

Country Status (4)

Country Link
EP (1) EP0994943A2 (fr)
AU (1) AU8631198A (fr)
GB (1) GB9714475D0 (fr)
WO (1) WO1999002659A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7632807B2 (en) 2004-10-06 2009-12-15 Albany Molecular Research, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928313A1 (de) * 1999-06-16 2000-12-21 Ullrich Keller Verfahren zur Veränderung von Peptidsynthefasen in der Weise, daß sie ihre Substrataminosäuren N-methylieren können
US6603902B1 (en) 1999-10-26 2003-08-05 Bti Photonics Inc. Wavelength selective variable reflector

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578616A2 (fr) * 1992-07-09 1994-01-12 Sandoz Ltd. Cyclosporin synthétase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578616A2 (fr) * 1992-07-09 1994-01-12 Sandoz Ltd. Cyclosporin synthétase

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A. LAWEN AND R. TRABER: "Substrates specificities of cyclosporin synthetase and peptolide SDZ 214-103 synthetase", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 27, 1993, pages 20452 - 20465, XP002094831 *
G. WEBER ET AL.,: "The peptide synthetase catalyzing cyclosporine production in Tolypocladium niveum is encoded by a giant 45.8-kilobase open reading frame", CURRENT GENETICS, vol. 26, no. 2, 1994, pages 120 - 125, XP002094832 *
H. HUSI ET AL.,: "Prediction of substrate-specific pockets in cyclosporin synthetase", FEBS LETTERS, vol. 414, no. 3, - 15 September 1997 (1997-09-15), pages 532 - 536, XP002094835 *
J. DITTMANN ET AL.,: "Mechanism of cyclosporin A biosynthesis", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 4, 1994, pages 2841 - 2846, XP002094833 *
T. STACHELHAUS AND M.A. MARAHIEL: "Modular structure of genes encoding multifunctional peptide synthetases required for non-ribosomal peptide synthesis", FEMS MICROBIOLOGY LETTERS, vol. 125, no. 1, 1995, pages 3 - 14, XP002094834 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7632807B2 (en) 2004-10-06 2009-12-15 Albany Molecular Research, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents

Also Published As

Publication number Publication date
GB9714475D0 (en) 1997-09-17
AU8631198A (en) 1999-02-08
WO1999002659A2 (fr) 1999-01-21
EP0994943A2 (fr) 2000-04-26

Similar Documents

Publication Publication Date Title
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
AU7489596A (en) Reinforced formed part, process for its production and its use
WO2001079461A3 (fr) Polypeptides a activite haloperoxydase
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU6136499A (en) Injector, methods for using injector, and kit
AU6131198A (en) Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells
AU6059699A (en) Synthetic peptides, conjugation reagents and methods
AU8562898A (en) Thienopyridine derivatives, intermediates thereof, and process for producing theboth
WO2001014566A3 (fr) Synthese enzymatique de desoxyribonucleosides
AU2046297A (en) Method for the manufacture of ammonia
IL145004A0 (en) Non-ribosomal peptide synthetases, method for the production thereof and use thereof
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
WO2000022019A3 (fr) Copolymeres sequences couples, et procede de production desdits copolymeres sequences
WO1999002659A3 (fr) Procede de modification des domaines de la cyclosporine synthetase pour l'obtention d'une cyclosporine synthetase modifiee
AU3732400A (en) Clockworks, timepiece and method for operating the same
AU5696796A (en) Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
AU1534999A (en) Weather-resistant mineral and protein supplement feeds, and methods of making same
AU2406597A (en) Thienopyridine derivatives, their production and use
AU6601096A (en) Dax-1 protein, methods for production and use thereof
WO1999010480A3 (fr) Nouvelles calpaines specifiques au tissu, leur production et leur utilisation
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
AU6123396A (en) Imidazo{1,5a}pyridine derived serine protease inhibitors
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1998937563

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1998937563

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998937563

Country of ref document: EP